Alexion makes $930M acquisition in bid to bolster blockbuster drug By: Boston Business Journal via Business Journals October 16, 2019 at 11:43 AM EDT Alexion says it will acquire clinical-stage startup Achillion Pharmaceuticals Inc. for $930 million upfront. Read More >>
